基因组编辑
Cas9
引导RNA
清脆的
生物
核糖核蛋白
脂质体
基因传递
基因
遗传增强
脂质体
核糖核酸
分子生物学
计算生物学
生物化学
重组DNA
载体(分子生物学)
作者
Jing Gong,Hongxia Wang,Yeh‐Hsing Lao,Hanze Hu,Naazanene Vatan,Jonathan Guo,Tzu‐Chieh Ho,Danyang Huang,Mingqiang Li,Dan Shao,Kam W. Leong
标识
DOI:10.1002/adma.202003537
摘要
Recent advances in CRISPR present attractive genome-editing toolsets for therapeutic strategies at the genetic level. Here, a liposome-coated mesoporous silica nanoparticle (lipoMSN) is reported as an effective CRISPR delivery system for multiplex gene-editing in the liver. The MSN provides efficient loading of Cas9 plasmid as well as Cas9 protein/guide RNA ribonucleoprotein complex (RNP), while liposome-coating offers improved serum stability and enhanced cell uptake. Hypothesizing that loss-of-function mutation in the lipid-metabolism-related genes pcsk9, apoc3, and angptl3 would improve cardiovascular health by lowering blood cholesterol and triglycerides, the lipoMSN is used to deliver a combination of RNPs targeting these genes. When targeting a single gene, the lipoMSN achieved a 54% gene-editing efficiency, besting the state-of-art Lipofectamine CRISPRMax. For multiplexing, lipoMSN maintained significant gene-editing at each gene target despite reduced dosage of target-specific RNP. By delivering combinations of targeting RNPs in the same nanoparticle, synergistic effects on lipid metabolism are observed in vitro and vivo. These effects, such as a 50% decrease in serum cholesterol after 4 weeks of post-treatment with lipoMSN carrying both pcsk9 and angptl3-targeted RNPs, could not be reached with a single gene-editing approach. Taken together, this lipoMSN represents a versatile platform for the development of efficient, combinatorial gene-editing therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI